Results 51 to 60 of about 34,375 (153)

Synthèse Rencontre Santé Numérique - Informatisation et tableaux de bord - Continuum de soins et services en cancérologie au CISSS de Laval

, 2023
<p>Depuis 2013, le Centre intégré de cancérologie de Laval a procédé à l'informatisation de tous les processus clés avec une approche novatrice. Lors de ce webinaire, Dre Marie-Andrée Fortin a présenté un survol de l'informatisation clinique, ainsi
Consortium Santé Numérique
core   +1 more source

Characterizing the Fate of Anti‐CS1 Nanobody Displaying Extracellular Vesicles in Multiple Myeloma

Journal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
ABSTRACT Extracellular vesicles (EVs) are promising delivery vehicles capable of transporting therapeutic agents across biological barriers. However, native EVs primarily accumulate in liver, spleen and lungs, limiting targeted delivery to disease sites.
Michiel De Coster, Lukas Hyka, Sophie De Cock, Sofie Meeussen, Zuowei Wang, Chenggong Tu, Sophie Hernot, Nick Devoogdt, Guido David, Kim De Veirman, Karin Vanderkerken, Eline Menu, Pascale Zimmermann, Elke De Bruyne   +13 more
wiley   +1 more source

Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025

European Journal of Haematology, Volume 116, Issue 6, Page 724-732, June 2026.
ABSTRACT Minimal residual disease (MRD) is a central biomarker in multiple myeloma (MM), offering unprecedented sensitivity for evaluating treatment efficacy and serving as a potential surrogate endpoint. We conducted a comprehensive analysis of clinical trials registered on ClinicalTrials.gov between 2014 and 2025.
Mimi Choon‐Quinones, George Dennis Obeng, Benjamin Asiedu‐Ayeh, Sampson Kawuo, Asmau Mohammed Tukur, Inusah Mohammed, Akosua Pokuaah Obeng, Jean‐Luc Harousseau, Anja Seckinger, Dirk Hose, Emmanuel Sarkodie, Attila Imre, Marcell Csanádi   +12 more
wiley   +1 more source

Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment

Journal of Neuroendocrinology, Volume 38, Issue 6, June 2026.
Abstract Neuroendocrine tumours (NETs) are well‐differentiated epithelial neuroendocrine neoplasms that frequently develop in the small intestine, pancreas, and lungs. NETs originate from neuroendocrine cells specialized in hormone secretion implicated in a number of physiological processes.
Victoria Jacquot, Benjamin Chevalier, Thomas Walter, Benjamin Gibert, Maria Ouzounova   +4 more
wiley   +1 more source

Kasimir : portail sémantique pour la gestion des connaissances en cancérologie

, 2004
Colloque sans acte à diffusion restreinte. nationale.National audienceLe projet Kasimir est un projet pluridisciplinaire regroupant médecins cancérologues, informaticiens et ergonomes, avec pour objectif la gestion de connaissances médicales, en ...
Brachais, Sébastien, Napoli, Amedeo, d'Aquin, Mathieu, Lieber, Jean   +3 more
core   +1 more source

Issue Information

Cancer Medicine, Volume 15, Issue 7, July 2026.
wiley   +2 more sources

RIP140 regulates transcription factor HES1 oscillatory expression and mitogenic activity in colon cancer cells

Molecular Oncology
The transcription factor receptor‐interacting protein 140 (RIP140) regulates intestinal homeostasis and tumorigenesis through Wnt signaling. In this study, we investigated its effect on the Notch/HES1 signaling pathway.
Nour Sfeir, Marilyn Kajdan, Stéphan Jalaguier, Sandrine Bonnet, Catherine Teyssier, Samuel Pyrdziak, Rong Yuan, Emilie Bousquet, Antonio Maraver, Florence Bernex, Nelly Pirot, Florence Boissière‐Michot, Audrey Castet‐Nicolas, Marion Lapierre, Vincent Cavaillès   +14 more
doaj   +1 more source

Patient‐ and caregiver‐reported barriers to chemotherapy in nine sub‐Saharan African countries: A cross‐sectional survey among population‐based registries

International Journal of Cancer, Volume 158, Issue 10, Page 2684-2696, 15 May 2026.
What's New? Increasing cancer incidence and mortality in low‐ and middle‐income countries has heightened concerns about limited resources and barriers to care. This challenge is particularly urgent in Sub‐Saharan Africa (SSA), where cancer rates are rising sharply. Here, data from population‐based cancer registries in nine SSA countries was assessed to
Tamara König, Nikolaus Christian Simon Mezger, Ole Stoeter, Phoebe Mary Amulen, Margaret Borok, Gladys C. Chesumbai, Moudiongui MBoungou Dimitry, Ima‐Obong Ekanem, Adugna Fekadu, Bakarou Kamaté, William Muller, Alex Alain Kabena Nzambikolo, Abidemi Omonisi, Furaha Serventi, Markus Wallwiener, Biying Liu, Donald Maxwell Parkin, Pablo Sandro Carvalho Santos, Eva Johanna Kantelhardt, Eric Sven Kroeber   +19 more
wiley   +1 more source

Sevrage tabagique en cancérologie : que nous apprennent les patients? Perspectives pour l’ETP

, 2016
Près de 2 fumeurs sur 3 n’arrêtent pas de fumer après un diagnostic de cancer. La majorité trouve qu’il est très difficile d’arrêter et près de la moitié souhaite être aidé dans leur démarche. À ce jour, il n’existe pas de programme d’
Baussard, Louise, Aline Lasserre Moutet, Marie-Ève Huteau, Aline Morichaud, Lasserre Moutet, Aline, Stoebner-Delbarre, Anne, Morichaud, Aline, Louise Baussard, Anne Stoebner-Delbarre, Huteau, Marie-Ève   +9 more
core   +1 more source

La cancérologie du furet (Mustela putorius furo) [PDF]

, 2006
La cancérologie du furet est en pleine évolution. De nombreux types tumoraux sont rapportés. Ils touchent tous les systèmes de l organisme ; endocrinien, hémolymphatique, cutané, digestif, reproducteur, musculosquelettique, cardiovasculaire, nerveux ...
DUCOS DE LAHITTE, Jacques, BUNEL LE COZ, Bertrand   +1 more
core   +1 more source